These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Resection margins and R1 rates in pancreatic cancer--are we there yet? Verbeke CS Histopathology; 2008 Jun; 52(7):787-96. PubMed ID: 18081813 [TBL] [Abstract][Full Text] [Related]
23. Expression of S100A2 calcium-binding protein predicts response to pancreatectomy for pancreatic cancer. Biankin AV; Kench JG; Colvin EK; Segara D; Scarlett CJ; Nguyen NQ; Chang DK; Morey AL; Lee CS; Pinese M; Kuo SC; Susanto JM; Cosman PH; Lindeman GJ; Visvader JE; Nguyen TV; Merrett ND; Warusavitarne J; Musgrove EA; Henshall SM; Sutherland RL; Gastroenterology; 2009 Aug; 137(2):558-68, 568.e1-11. PubMed ID: 19376121 [TBL] [Abstract][Full Text] [Related]
24. [Evidence based surgery of cancer of head of pancreas]. Launois B; Huguier M Bull Acad Natl Med; 2004; 188(5):743-52; discussion 753-4. PubMed ID: 15656235 [TBL] [Abstract][Full Text] [Related]
25. Clinical presentation and waiting time targets do not affect prognosis in patients with pancreatic cancer. Raptis DA; Fessas C; Belasyse-Smith P; Kurzawinski TR Surgeon; 2010 Oct; 8(5):239-46. PubMed ID: 20709279 [TBL] [Abstract][Full Text] [Related]
26. Survival after pancreaticoduodenectomy is not improved by extending resections to achieve negative margins. Hernandez J; Mullinax J; Clark W; Toomey P; Villadolid D; Morton C; Ross S; Rosemurgy A Ann Surg; 2009 Jul; 250(1):76-80. PubMed ID: 19561479 [TBL] [Abstract][Full Text] [Related]
27. Multi-institutional pooled analysis on adjuvant chemoradiation in pancreatic cancer. Morganti AG; Falconi M; van Stiphout RG; Mattiucci GC; Alfieri S; Calvo FA; Dubois JB; Fastner G; Herman JM; Maidment BW; Miller RC; Regine WF; Reni M; Sharma NK; Ippolito E; Valentini V Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):911-7. PubMed ID: 25220717 [TBL] [Abstract][Full Text] [Related]
28. Margin status impacts survival after pancreaticoduodenectomy but negative margins should not be pursued. Mathur A; Ross SB; Luberice K; Kurian T; Vice M; Toomey P; Rosemurgy AS Am Surg; 2014 Apr; 80(4):353-60. PubMed ID: 24887665 [TBL] [Abstract][Full Text] [Related]
29. Adjuvant intra-arterial chemotherapy and radiotherapy versus surgery alone in resectable pancreatic and periampullary cancer: a prospective randomized controlled trial. Morak MJ; van der Gaast A; Incrocci L; van Dekken H; Hermans JJ; Jeekel J; Hop WC; Kazemier G; van Eijck CH Ann Surg; 2008 Dec; 248(6):1031-41. PubMed ID: 19092348 [TBL] [Abstract][Full Text] [Related]
30. Critical appraisal of 232 consecutive distal pancreatectomies with emphasis on risk factors, outcome, and management of the postoperative pancreatic fistula: a 21-year experience at a single institution. Goh BK; Tan YM; Chung YF; Cheow PC; Ong HS; Chan WH; Chow PK; Soo KC; Wong WK; Ooi LL Arch Surg; 2008 Oct; 143(10):956-65. PubMed ID: 18936374 [TBL] [Abstract][Full Text] [Related]
31. Preoperative diabetes mellitus and long-term survival after resection of pancreatic adenocarcinoma. Chu CK; Mazo AE; Goodman M; Egnatashvili V; Sarmiento JM; Staley CA; Galloway JR; Adsay NV; Jacobs S; Kooby DA Ann Surg Oncol; 2010 Feb; 17(2):502-13. PubMed ID: 19885697 [TBL] [Abstract][Full Text] [Related]
32. The Impact of Positive Resection Margins on Survival and Recurrence Following Resection and Adjuvant Chemotherapy for Pancreatic Ductal Adenocarcinoma. Ghaneh P; Kleeff J; Halloran CM; Raraty M; Jackson R; Melling J; Jones O; Palmer DH; Cox TF; Smith CJ; O'Reilly DA; Izbicki JR; Scarfe AG; Valle JW; McDonald AC; Carter R; Tebbutt NC; Goldstein D; Padbury R; Shannon J; Dervenis C; Glimelius B; Deakin M; Anthoney A; Lerch MM; Mayerle J; Oláh A; Rawcliffe CL; Campbell F; Strobel O; Büchler MW; Neoptolemos JP; Ann Surg; 2019 Mar; 269(3):520-529. PubMed ID: 29068800 [TBL] [Abstract][Full Text] [Related]
33. Outcomes after resection of locally advanced or borderline resectable pancreatic cancer after neoadjuvant therapy. Barugola G; Partelli S; Crippa S; Capelli P; D'Onofrio M; Pederzoli P; Falconi M Am J Surg; 2012 Feb; 203(2):132-9. PubMed ID: 21824596 [TBL] [Abstract][Full Text] [Related]
35. Resection of cancer of the body and tail of the pancreas. Burcharth F; Trillingsgaard J; Olsen SD; Moesgaard F; Federspiel B; Struckmann JR Hepatogastroenterology; 2003; 50(50):563-6. PubMed ID: 12749273 [TBL] [Abstract][Full Text] [Related]
36. Impact of previous tracheotomy as a prognostic factor in patients with locally advanced squamous cell carcinoma of the larynx submitted to concomitant chemotherapy and radiation. Herchenhorn D; Dias FL; Ferreira CG; Araújo CM; Lima RA; Small IA; Kligerman J ORL J Otorhinolaryngol Relat Spec; 2008; 70(6):381-8. PubMed ID: 18984974 [TBL] [Abstract][Full Text] [Related]
37. Adenosquamous carcinoma of the pancreas: a single-institution experience comparing resection and palliative care. Smoot RL; Zhang L; Sebo TJ; Que FG J Am Coll Surg; 2008 Sep; 207(3):368-70. PubMed ID: 18722942 [TBL] [Abstract][Full Text] [Related]
38. The treatment of pancreatic cancer. Yeo CJ; Cameron JL Ann Chir Gynaecol; 2000; 89(3):225-33. PubMed ID: 11079793 [No Abstract] [Full Text] [Related]
39. Laparoscopic surgery of pancreatic cancer: state of the art. Croce E; Olmi S; Bertolini A; Magnone S Hepatogastroenterology; 2005; 52(66):1889-94. PubMed ID: 16334801 [TBL] [Abstract][Full Text] [Related]